FIELD: chemistry.
SUBSTANCE: invention relates to a method for selective binding and extraction of at least one component from whole blood or humour, where the blood or humour is allowed to pass through a hard integrated separating matrix without leaking from it. The matrix has a porous structure with pore size ranging from 5 mcm to 500 mcm, as well as an active surface whose area ranges from 0.5 cm2 to 10 m2, and this surface is cable of binding such components.
EFFECT: invention enables to obtain high flow rate in a separating device without pressure drop arising with time, avoiding the effect of shearing force on the blood even at high flow rate while maintaining low pressure in the line in order to prevent damage to blood vessels, providing selective binding or separation of a component from whole blood or humour and eliminating inflammatory processes without the need to split blood into plasma and blood cells.
17 cl, 6 dwg, 2 tbl, 35 ex
Title | Year | Author | Number |
---|---|---|---|
IMPROVED SEPARATION | 2003 |
|
RU2311183C2 |
CHAPERONIN 10 MODULATION OF TOLL-LIKE RECEPTOR INDUCIBLE CYTOKINE AND CHEMOKINE SECRETION | 2005 |
|
RU2446817C2 |
USE OF ANTIBODY FRAGMENT IN THERAPY | 1994 |
|
RU2139092C1 |
AFFINE SORBENT FOR REMOVAL OF TUMOR NECROSIS FACTOR AND METHOD OF ITS PREPARING | 1995 |
|
RU2123860C1 |
COMPOSITION BASED UPON THE PROTEINS OF ENAMEL MATRIX FOR MODULATING IMMUNE RESPONSE | 2002 |
|
RU2295972C2 |
ANTIBODY PURIFICATION METHOD | 2005 |
|
RU2389552C2 |
GLUCOSAMINE DISACCHARIDES, METHOD OF PREPARING THEREOF, AND PHARMACEUTICAL COMPOSITION | 1994 |
|
RU2154068C2 |
METHOD OF REMOVING ENDOTOXINS FROM BIOLOGICAL FLUIDS USING COVALENTLY IMMOBILIZED LYSOZYME AS LIGAND | 2018 |
|
RU2684639C1 |
METHOD FOR REMOVING TUMOR NECROTIZING FACTOR FROM LIQUID MEDIUM | 1995 |
|
RU2112553C1 |
CHROMATOGRAPHIC LIGAND | 2005 |
|
RU2396246C2 |
Authors
Dates
2011-09-27—Published
2007-03-21—Filed